About the Author: Dr Moustapha Hamdi, MD, PhD, is Professor and Chairman of Plastic and Reconstructive Surgery, Department Brussels University Hospital, Brussels, Belgium. Born in Syria, he graduated from medical school at Damascus University and completed his training in general and plastic surgery in Brussels, Glasgow and Atlanta. He has worked as a Professor in Ghent University for 10 years. Currently, he is the head of the department of Plastic- and Reconstructive Surgery at the University Hospital of Brussels. He is also the founder of Lymph Clinic and leading surgeon at the Delta Hospital - Chirec Group. Recently, Prof. Hamdi has established his own foundation to support breast cancer research and patients. He has been speaker and organizer of many meetings and courses in Breast Surgery. His major expertise is breast reconstruction, mainly with perforator flaps. Prof. Hamdi authored over 140 peer-review papers, 40 chapters in books and edited 6 books. Former president of the Royal Belgian Society for Plastic Surgery (RBSPS), member of the Belgian Board of Plastic Surgery and expert member of the high council of Ministry of health in Belgium. scientific committee of the European Society of Plastic Surgeons (EURAPS); in addition, he is an honorary member in Australian, Colombian and Syrian societies and a member of the British (BAPS), International (ISAPS), American (ASPS and ASRM) and the World Society of Microsurgery (WSRM).
Dr Raghavan Vidya MS, MD, FRCS is a Senior lecturer at Birmingham University and Consultant Oncoplastic breast surgeon at the Royal Wolverhampton NHS Trust. She graduated from University of Madras, India followed by Postgraduate training in General Surgery. She completed her MD (Research) on aromatase inhibitors from University of Edinburgh and higher surgical training in Wessex and West Midlands. Dr Vidya is a faculty in several National and International meetings and has more than 100 peer-reviewed publications. She has introduced and mentored new innovations including muscle-sparing implant-based breast reconstruction. She produced the report of Future of Surgery of the Royal College of Surgeons as a National member of ABS Breast academic Group. She is the lead for the Royal College of Surgeons (RCS) International Surgical training programme (ISTP) in Breast Surgery. She is Associate Director of West Midlands, Genomic Medicine Service Alliance (GMSA). Dr Vidya has founded the Virtual Global Breast Hub, to bring together global experts on a single platform. She is actively involved in clinical trials and has a special interest in Oncoplastic Breast Surgery, new technology and advances in breast surgery. She is an active member of Association of Breast Surgery UK (ABS), European Society of Surgical Oncology (ESSO), Breast Surgery International (BSI), Asian and Indian Society of Breast Surgery.
Dr Amit Agrawal MBBS, MS, DM, FRCS graduated from the University of Calcutta, India, and completed his Academic surgical training and research at the University of Nottingham, UK. He is a Consultant Oncoplastic Breast Surgeon at Cambridge University Hospitals, UK. He is Lead for breast surgical quality control, having transformed the Cambridge Breast Unit into an Oncoplastic Unit by introducing Breast-Surgeon led advanced Oncoplastic operations (such as therapeutic mammaplasty and mastopexy, chest wall perforator flap partial and pre-pectoral implant-ADM whole breast reconstruction). He is founder-director of the international Cambridge chest wall perforator flap and breast reconstruction dissection course; and lectures internationally on Oncoplastic surgery and related controversies. He is Examiner and Research module Lead for the MSc & MS Oncoplastic Breast Surgery, University of East Anglia, UK. Further, he is current member of the Education and Training committee (and elect member of the Academic and Research committee) of the UK Association of Breast Surgery, founder-member of British-Bangla Breast Group, as well as a member of British Breast Group, IndoUK Breast Forum, and European Society of Surgical Oncology. He has 100+ publications and presentations, many following lab-based research in endocrine therapy in Breast Cancer (focusing on resistance mechanisms especially following Fulvestrant therapy) as an Academic in Breast Surgery, University of Nottingham where he was investigator in multiple trials and continues to do so. In addition, he is Expert Reviewer, NICE (National Institute for Health and Care Excellence, UK) Interventional Technology besides reviewer for many breast-specific journals.
